Pfizer (PFE) Raises Quarterly Dividend 2.6% to $0.39; 3.7% Yield
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/1/2026
- Equities rebound to close higher as surging Treasury yields recede
- Fed’s Jefferson sees no urgency for another rate increase
- Oil jumps 4% on reports China halts fuel exports, US troops head to Middle East
- Amazon and these four U.S. stocks are latest additions to Goldman’s flagship list
- Anthropic targets mid-November for public debut - report
- Zimbabwe helicopter crash kills six, government spokesperson says
- Apple's iOS 27 is blocking Trade Desk ads on Safari, analyst says
- DataMeds AI's Corexa Pharmacy tops $1M in monthly revenue
- S&P 500 dips, Nasdaq higher after data shows moderate inflation rise
- Equities rebound to close higher as surging Treasury yields recede
Pfizer (PFE), BioNTech SE (BNTX) Highlight Data on Neutralizing Antibody & T-Cell Responses from Phase 1/2 Trial with BNT162b2 Conducted in Germany
December 14, 2020 6:16 AM ESTPfizer Inc. (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) today announced additional data on neutralizing antibody and T cell responses from the Phase 1/2... More
